Homepage Articles Astaxanthin - Organic Pigment with Beneficial Attributes
Source

Bertram J.S., Vine A.L., Cancer prevention by retinoids and carotenoids: Independent action on a common target, „Biochimica et Biophysica Acta” 2005, 1740(2), 170–178.
Choi H., Youn Y., Shin W., Positive Effects of Astaxanthin on Lipid Profiles and Oxidative Stress in Overweight Subjects, „Plant Foods for Human Nutrition” 2011, 66(4), 363–369.
Fakhri S. et al., The Neuroprotective Effects of Astaxanthin: Therapeutic Targets and Clinical Perspective, „Molecules” 2019, 24(14), epub.
Faraone I. et al., Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: A systematic review, „Pharmacological Research” 2020, 155, epub.
Galasso Ch., On the Neuroprotective Role of Astaxanthin: New Perspectives?, „Marine Drugs” 2018, 16(8), epub.
Genest J., C-reactive protein: Risk factor, biomarker and/or therapeutic target?, „The Canadian Journal of Cardiology” 2010, 26 (suppl. A), 41–44.
Jyonouchi H. et al., Antitumor Activity of Astaxanthin and Its Mode of Action, „Nutrition and Cancer” 2000, 36(1), 59–65.
Karppi J. et al., Effects of Astaxanthin Supplementation on Lipid Peroxidation, „International Journal for Vitamin and Nutrition Research” 2007, 77(1), 3–11.
Kishimoto Y., Yoshida H., Kondo K., Potential Anti-Atherosclerotic Properties of Astaxanthin, „Marine Drugs” 2016, 14(2), epub.
Li J., Guo C., Wu J., Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent, „Drug Design, Development and Therapy” 2020, 2020(14), 2275–2284.
Lis K., Kołoczek H., Znaczenie żywności funkcjonalnej, nutraceutyków, w tym astaksantyny w żywieniu człowieka, Zdrowie i style życia. Determinanty długości życia, pod red. Nowak W., Szalonki K., Wrocław 2020, 115–131.
Mashhadi N.S. et al., Astaxanthin improves glucose metabolism and reduces blood pressure in patients with type 2 diabetes mellitus, „Asia Pacific Journal of Clinical Nutrition” 2018, 27(2), 341–346.
Naguib Y., Antioxidant Activities of Astaxanthin and Related Carotenoids, „Journal of Agricultural and Food Chemistry” 2000, 48(4), 1150–1154.
Palloza P. et al., Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells, „Cancer Letters” 2009, 283(1), 108–117.
Park J. et al., Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans, „Nutrition & Metabolism” 2010, 7, epub.
Pogorzelska E., Hamułka J., Wawrzyniak A., Astaksantyna – budowa, właściwości i możliwości zastosowania w żywności funkcjonalnej, „Żywność. Nauka. Technologia. Jakość” 2016, 1(104), 5–16.
Sieradzka M., Kołodziejczyk-Czepas J., Astaksantyna – karotenoidowy przeciwutleniacz o właściwościach kardioprotekcyjnych, „Problemy Higieny i Epidemiologii” 2016, 97(3), 197–206.
Yoshida H. et al., Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia, „Atherosclerosis” 2010, 209(2), 520–523.